Climate Change Data

Alliance Pharma plc

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:48,025 tCO2e (2022)
Scope 1 Emissions:22 tCO2e (2022)
Scope 2 Emissions:50 tCO2e (2022)
Scope 3 Emissions:47,973 tCO2e (2022)
Carbon Intensity:279 tCO2e per £m of revenue (2022)

ESG Focus Areas

  • People
  • Planet
  • Product

Environmental Achievements

  • Offset Scope 1 & 2 UK emissions for 2021
  • 65% reduction in Scope 1 & 2 emissions (versus 2018 baseline) by 2025 target set
  • Net zero (90% absolute reduction) by 2030 target set for Scope 1 & 2 emissions

Social Achievements

  • 80 new heads brought into the business in 2022 – 18 of which were in newly created roles
  • New UK graduate and industry placement schemes rolled out
  • High levels of employee engagement maintained with increased GPTW survey participation and trust index ratings; additional certifications achieved in US and France
  • First all-employee conference held
  • More targeted approach to online compliance training, driving an increase in course completion rates
  • Compliance training provision further enhanced through partnering with new external providers
  • Partner code of conduct published

Governance Achievements

  • Integrated climate governance into existing corporate governance structures
  • Created a stand-alone climate risk management framework and integrated it into wider business risk management processes

Climate Goals & Targets

Medium-term Goals:
  • Achieve net zero (90% absolute reduction) in Scope 1 & 2 emissions by 2030
  • Set targets for specific categories of Scope 3 emissions
Short-term Goals:
  • Achieve a 65% reduction in Scope 1 & 2 emissions (versus 2018 baseline) by 2025

Environmental Challenges

  • Reducing the environmental impact of product packaging (particularly blister packs containing non-recyclable PVC)
  • Developing Scope 3 emissions reduction targets
  • Climate-related risks impacting operations and supply chain (flooding, heatwaves, wildfires, sea level rise, water stress)
  • Transition risks (increased regulation, carbon pricing, changing consumer preferences, etc.)
Mitigation Strategies
  • Initiated pilot projects to explore more sustainable packaging options (plastic tubes, rigid packaging, blister packs)
  • Embedding ownership of product-related emissions within functional areas
  • Methodology improvements to increase accuracy of emissions measurement
  • Climate scenario analysis and risk assessment to understand climate-related risks
  • Developing relationships with partners to support knowledge sharing on climate risks and opportunities
  • Extending climate risk analysis to other key partners in the value chain
  • Setting Scope 1 & 2 emissions targets

Supply Chain Management

Responsible Procurement
  • Partner code of conduct published
  • Obtaining confirmation from CMOs that they comply with ethical standards
  • Tightening processes around modern slavery

Climate-Related Risks & Opportunities

Physical Risks
  • Flooding
  • Heatwaves/extreme heat
  • Wildfires
  • Rising mean temperatures
  • Sea level rise
  • Water stress
Transition Risks
  • Increased regulation due to climate change
  • Increase in carbon pricing
  • Mandates on and regulation of existing products and services
  • Increased cost of energy and materials
  • Changing consumer preferences
  • Increased stakeholder concern damaging reputation
  • Substitution of existing products with lower emissions alternatives
  • Costs to transition to lower emissions technology
Opportunities
  • Development of new products or services
  • Use of lower-emission sources of energy

Reporting Standards

Frameworks Used: TCFD

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:50,138 tCO2e/year (Scope 1 & 2: 59 tCO2e)
Scope 1 Emissions:0 tCO2e/year
Scope 2 Emissions:59 tCO2e/year
Scope 3 Emissions:50,125 tCO2e/year
Renewable Energy Share:100% (UK and Germany)
Carbon Intensity:0.81 tCO2e per £m of revenue (2023)

ESG Focus Areas

  • People
  • Planet
  • Product

Environmental Achievements

  • 48% reduction in Scope 1 and 2 emissions (versus 2018 baseline), on track to meet interim 65% reduction target by 2025 and achieve net zero in 2030. Scope 3 emissions target set to achieve net zero by 2044 (versus 2022 baseline), with an interim reduction target of 25% by 2030.
  • Nizoral™ manufacturing moved from Belgium to Thailand driving cost savings, improving on-time-in-full order delivery and reducing carbon emissions.

Social Achievements

  • Re-certified as a Great Place To Work® in UK, US, China and Singapore.
  • Launched our Employee Code of Conduct, continued to embed our Partner Code of Conduct and strengthened our suite of policy documents.
  • Introduced a new, more comprehensive programme of online compliance training to upskill our employees and contractors.
  • Entered a three-year partnership with the social enterprise Slave Free Alliance (“SFA”) to safeguard individuals across our business from modern slavery and human trafficking, including those in our supply chain.

Governance Achievements

  • Strengthened Board of Directors with appointment of Jeyan Heper, Martin Sutherland, Richard McKenzie and Eva-Lotta Sjöstedt. Post year end appointments of new Independent Chair, Camillo Pane and new CEO, Nick Sedgwick.
  • Successful appeal of Competition and Markets Authority decision clearing Alliance, Peter Butterfield and John Dawson (former CEOs) of any wrongdoing.

Climate Goals & Targets

Long-term Goals:
  • Achieve net zero Scope 3 emissions by 2044
Medium-term Goals:
  • Achieve 65% reduction in absolute Scope 1 and 2 emissions by 2025 (versus 2018 baseline)
  • Achieve 25% reduction in absolute Scope 3 emissions by 2030 (versus 2022 baseline)
  • Achieve net zero Scope 1 and 2 emissions by 2030
  • Achieve 10% of Consumer Healthcare sales through products developed on our I&D platform within the next five years
Short-term Goals:
  • Reduce water consumption
  • Reduce waste
  • Develop sustainable packaging strategy with KPIs
  • Launch new packaging for Nizoral™ Derma Daily

Environmental Challenges

  • Challenging H1 performance due to unexpected regulatory issues causing manufacturing delays in certain smaller products and Amberen™ sales hampered by industry-wide challenges on Amazon.
  • Amberen™ revenues weaker than anticipated.
  • Less favourable product mix and increase in warehouse and distribution costs impacting gross profit growth.
  • Counterfeiting and illicit trade of Kelo-Cote™ in China.
  • Regulatory transition from the European Medical Device Directive (“MDD”) to the Medical Device Regulation (“MDR”) impacting supply of certain products.
Mitigation Strategies
  • Colleagues worked hard to address regulatory issues to ensure all products were back in stock by year-end.
  • Strong consumer demand for Kelo-Cote™ drove restocking in H2 and consumer activation campaigns delivered market share gains for Nizoral™.
  • Strengthening internal and external capabilities in ecommerce and digital marketing to mitigate future problems on Amazon.
  • Substantially reduced counterfeiting of Kelo-Cote™ in China through security measures.
  • Painstaking work from cross-functional team to resolve MDR transition issues, with all affected products back in stock.
  • Robust control of actively managed costs decreased operating costs by 5%.

Supply Chain Management

Supplier Audits: 93% of CMOs managed by our sourcing team have either signed up to our Partner Code of Conduct or provided us with a copy of their equivalent code.

Responsible Procurement
  • Partner Code of Conduct
  • Slave Free Alliance partnership
  • Modern Slavery Statement
  • Three-year anti-slavery strategy and action plan
  • Supplier lifecycle due diligence review

Climate-Related Risks & Opportunities

Physical Risks
  • Increased frequency and severity of flooding
Transition Risks
  • Regulatory changes
  • Market shifts towards sustainable products
Opportunities
  • Use of lower-emission energy sources
  • Increased demand for sustainable products and services
  • Enhanced reputation as a market leader in climate action

Reporting Standards

Frameworks Used: TCFD

Certifications: Great Place To Work®

Sustainable Products & Innovation

  • New packaging for Nizoral™ Derma Daily

Awards & Recognition

  • Best communication of Sustainability in the small cap category from the IR Society